Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
17 Sep 2024 |
MR04 |
Satisfaction of charge 115324580001 in full
|
|
|
28 Aug 2024 |
CS01 |
Confirmation statement made on 23 August 2024 with no updates
|
|
|
29 Sep 2023 |
AA |
Full accounts made up to 31 December 2022
|
|
|
31 Aug 2023 |
AD03 |
Register(s) moved to registered inspection location Mills & Reeve Llp 1 st. James Court Whitefriars Norwich Norfolk NR3 1RU
|
|
|
30 Aug 2023 |
CS01 |
Confirmation statement made on 23 August 2023 with no updates
|
|
|
29 Aug 2023 |
AD02 |
Register inspection address has been changed to Mills & Reeve Llp 1 st. James Court Whitefriars Norwich Norfolk NR3 1RU
|
|
|
28 Aug 2023 |
PSC02 |
Notification of Invox Pharma Limited as a person with significant control on 8 March 2023
|
|
|
28 Aug 2023 |
PSC07 |
Cessation of F-Star Therapeutics Inc as a person with significant control on 8 March 2023
|
|
|
10 May 2023 |
AP01 |
Appointment of Mr Neil Douglas Brewis as a director on 8 March 2023
|
|
|
10 May 2023 |
TM01 |
Termination of appointment of Neil Douglas Brewis as a director on 8 March 2023
|
|
|
17 Mar 2023 |
TM01 |
Termination of appointment of Eliot Richard Forster as a director on 8 March 2023
|
|
|
30 Aug 2022 |
AA |
Full accounts made up to 31 December 2021
|
|
|
23 Aug 2022 |
CS01 |
Confirmation statement made on 23 August 2022 with updates
|
|
|
23 Aug 2022 |
CS01 |
Confirmation statement made on 21 August 2022 with updates
|
|
|
14 Feb 2022 |
AA |
Group of companies' accounts made up to 31 December 2020
|
|
|
29 Nov 2021 |
AP01 |
Appointment of Mr Neil Douglas Brewis as a director on 26 November 2021
|
|
|
03 Sep 2021 |
CS01 |
Confirmation statement made on 21 August 2021 with updates
|
|
|
14 May 2021 |
TM02 |
Termination of appointment of John Paul Fitzpatrick as a secretary on 13 May 2021
|
|
|
12 May 2021 |
TM01 |
Termination of appointment of John Paul Fitzpatrick as a director on 1 April 2021
|
|
|
14 Apr 2021 |
MR01 |
Registration of charge 115324580001, created on 1 April 2021
|
|
|
16 Dec 2020 |
SH10 |
Particulars of variation of rights attached to shares
|
|
|
16 Dec 2020 |
SH08 |
Change of share class name or designation
|
|
|
09 Dec 2020 |
RESOLUTIONS |
Resolutions
-
RES13 ‐
Re-disaply ARTICLE5, 6 and 9.2(a)/co business 20/11/2020
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
09 Dec 2020 |
MA |
Memorandum and Articles of Association
|
|
|
04 Dec 2020 |
PSC02 |
Notification of F-Star Therapeutics Inc as a person with significant control on 20 November 2020
|
|